Heparin

Pharmaceutical
Heparin contamination may have been deliberate, FDA says

The New York Times | April 30, 2008

WASHINGTON - Federal drug regulators believe that a contaminant detected in a crucial blood thinner that has caused 81 deaths was added deliberately, something the Food and Drug Administration has only hinted at previously.




Pharmaceutical
U.S. identifies tainted heparin in 11 countries

The New York Times | April 22, 2008

WASHINGTON - A contaminated blood thinner from China has been found in drug supplies in 11 countries, and federal officials said Monday they had discovered a clear link between the contaminant and severe reactions now associated with 81 deaths in the United States.




Pharmaceutical
FDA thinks it has trigger in heparin deaths

CNN | April 21, 2008

New tests suggest how a contaminant in heparin - a blood thinner - may be connected to dozens of deaths, FDA officials said Monday.




Pharmaceutical
Heparin is now suspected in 62 fatalities across the U.S.

The New York Times | April 10, 2008

The number of suspicious deaths in the United States linked to the blood thinner heparin has risen to 62 from 19, with most of them reported this past December, January and February, according to the first detailed analyses of heparin fatalities by the Food and Drug Administration.




Pharmaceutical
Heparin recall has doctors watching supply

American Medical News | March 24, 2008
id="Btext1">Robert Ostfeld, MD, an attending cardiologist at Montefiore Medical Center in Bronx, N.Y., now thinks harder about how doctors at his institution use heparin. Does a particular patient really need it? Would another product be more appropriate?




Pharmaceutical
Baxter to proceed with recall of remaining heparin sodium vial products

Baxter | February 28, 2008
DEERFIELD, Ill.,  - Baxter International Inc. announced today that the company is proceeding with the voluntary recall of all remaining lots and doses of its heparin sodium injection multi-dose, single-dose vials and HEP-LOCK heparin flush products.




Pharmaceutical
Making heparin is a dirty job

The Wall Street Journal | February 21, 2008

Heparin sold by Baxter International in the U.S. has recently been associated with hundreds of adverse reactions and a few deaths. Scientific Protein Laboratories, Baxter's main supplier of the active ingredient in the blood thinner, says that the Yuan Intestine & Casing Factory isn't in its company's supply chain.